Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases
NCT ID: NCT04729920
Last Updated: 2021-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
43 participants
OBSERVATIONAL
2019-09-15
2020-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders
NCT00839033
Evaluation of the Impact on Swallowing of Non Invasive Ventilation
NCT01519388
Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive
NCT01225614
Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
NCT05982119
Mechanical Insufflation in the Philadelphia Amyotrophic Lateral Sclerosis Cohort (MI-PALS) Study
NCT06119087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
subjects with neuromuscular disease
Adult subjects with neuromuscular disease, with an active prescription of MI-E for more than 3 months
Mechanical insufflation/exsufflation device (MI-E)
download of device (MI-E) data and self-reported satisfaction with the device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mechanical insufflation/exsufflation device (MI-E)
download of device (MI-E) data and self-reported satisfaction with the device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of neuromuscular disease
* Active prescription of MI-E for more than 3 months
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ligue Pulmonaire Vaudoise
UNKNOWN
University Hospital, Geneva
OTHER
Centre Hospitalier Universitaire Vaudois
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GEORGIA MITROPOULOU
Cheffe de clinique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Pneumologie, CHUV
Lausanne, Canton of Vaud, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-01114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.